KITTU 2.0 - Prospective Multicenter Clinical Study to Evaluate AI-Supported Therapy Recommendations for Patients in Urological Oncology

KITTU 2.0 - Prospective Multicenter Clinical Study to Evaluate AI-Supported Therapy Recommendations for Patients in Urological Oncology - KITTU 2.0

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038200

Enrollment

1200

Registered

2025-11-05

Start date

2025-10-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development and Evaluation of AI-Supported Therapy Recommendations

Interventions

Group 1: Technical and content evaluation of the developed AI assistance tool “KITTU”: - Correct and complete manual extraction of relevant patient data in the time window between the registration dea

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Urological tumors (prostate-, renal cell- and urothelial cell carcinomas). Presentation at the interdisciplinary urological tumor conference.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
Technical and content evaluation of the developed AI assistance tool “KITTU”: - Correct and complete manual extraction of relevant patient data in the time window between the registration deadline and the tumor conference - Medically correct, evidence-based, individual therapy suggestions by KITTU (after completion of the recruitment phase) - Comparison of the recommendations of the tumor conference and the developed AI assistance tool “KITTU” (rate of agreement/disagreement between the two recommendations) (after completion of the recruitment phase)	—

Measure

Time frame

Technical and content evaluation of the developed AI assistance tool “KITTU”: - Correct and complete manual extraction of relevant patient data in the time window between the registration deadline and the tumor conference - Medically correct, evidence-based, individual therapy suggestions by KITTU (after completion of the recruitment phase) - Comparison of the recommendations of the tumor conference and the developed AI assistance tool “KITTU” (rate of agreement/disagreement between the two recommendations) (after completion of the recruitment phase)

—

Secondary

Measure	Time frame
Explainability (comprehensible justification of the individual KITTU therapy recommendation)	—

Countries

Germany

Contacts

Public ContactVerena Kauth

Urologie der Universitätsmedizin Mainz

Verena.Kauth@unimedizin-mainz.de+49 (0)6131-17 2331

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026